Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial.
Nina KimerHenning GrønbækRikard Gøran FredTorben HansenAtul Shahaji DeshmukhMathias MannFlemming BendtsenPublished in: BMJ open (2020)
The trial is registered in clinicaltrials.gov (NCT04072601) and in clinicaltrialsregister.eu (EudraCT 2019-001806-40) (Pre-results).